Bright Minds initiated at outperform by Baird, Longboard takeover cited

seekingalpha11-26

sutthirat sutthisumdang Baird initiated coverage of Bright Minds Biosciences (NASDAQ:DRUG) with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals (LBPH). Bright ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486888684?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1362707165/image_1362707165.jpg","is_english":true,"pubTime":"2024-11-26 23:22","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2486888684","market":"hk","top_or_hot":-1,"title":"Bright Minds initiated at outperform by Baird, Longboard takeover cited","media":"seekingalpha","content":"<div>\n<p>sutthirat sutthisumdang Baird initiated coverage of Bright Minds Biosciences (NASDAQ:DRUG) with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals (LBPH). Bright ...</p>\n\n<a href=\"https://seekingalpha.com/news/4335575-bright-minds-initiated-at-outperform-by-baird-longboard-takeover-cited\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bright Minds initiated at outperform by Baird, Longboard takeover cited</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBright Minds initiated at outperform by Baird, Longboard takeover cited\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-26 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4335575-bright-minds-initiated-at-outperform-by-baird-longboard-takeover-cited><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>sutthirat sutthisumdang Baird initiated coverage of Bright Minds Biosciences (NASDAQ:DRUG) with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals (LBPH). Bright ...</p>\n\n<a href=\"https://seekingalpha.com/news/4335575-bright-minds-initiated-at-outperform-by-baird-longboard-takeover-cited\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DRUG","symbol_name":"Bright Minds Biosciences Inc","start_time":0,"source_url":"https://seekingalpha.com/news/4335575-bright-minds-initiated-at-outperform-by-baird-longboard-takeover-cited","article_id":"2486888684","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1362707165/image_1362707165.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486888684","pubTimestamp":1732634523,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"sutthirat sutthisumdang Baird initiated coverage of Bright Minds Biosciences  with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals . Bright Minds'  lead agent, BMB-101, is a 5-HT2C agonist entering Phase 2 testing for developmental epileptic encephalopathy, or DEE, and absence","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"DRUG":"Bright Minds Biosciences Inc"},"translate_title":"贝尔德(Baird)发起的Bright Minds表现优于大盘，长板收购被引用","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DRUG":0.9},"content_text":"sutthirat sutthisumdang Baird initiated coverage of Bright Minds Biosciences (NASDAQ:DRUG) with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals (LBPH). Bright Minds' (DRUG) lead agent, BMB-101, is a 5-HT2C agonist entering Phase 2 testing for developmental epileptic encephalopathy, or DEE, and absence","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486888684"}